Structure-activity relationship study of Aib-containing amphipathic helical peptide-cyclic RGD conjugates as carriers for siRNA delivery
Carriers for siRNA: PI: acetyl-KLULKLULKULKAULKLUGC(cRGDfC)-NH2; PII: acetyl-C(cRGDfC)KLULKLULKULKAULKLUG-NH2; PIII: acetyl-C(cRGDfC)KLULKLULKULKAULKLUGC(cRGDfC)-NH2. [Display omitted] The conjugation of Aib-containing amphipathic helical peptide with cyclo(-Arg-Gly-Asp-d-Phe-Cys-) (cRGDfC) at the C...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 27; no. 24; pp. 5378 - 5381 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
15.12.2017
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Carriers for siRNA: PI: acetyl-KLULKLULKULKAULKLUGC(cRGDfC)-NH2; PII: acetyl-C(cRGDfC)KLULKLULKULKAULKLUG-NH2; PIII: acetyl-C(cRGDfC)KLULKLULKULKAULKLUGC(cRGDfC)-NH2.
[Display omitted]
The conjugation of Aib-containing amphipathic helical peptide with cyclo(-Arg-Gly-Asp-d-Phe-Cys-) (cRGDfC) at the C-terminus of the helix peptide (PI) has been reported to be useful for constructing a carrier for targeted siRNA delivery into cells. In order to explore structure–activity relationships for the development of potential carriers for siRNA delivery, we synthesized conjugates of Aib-containing amphipathic helical peptide with cRGDfC at the N-terminus (PII) and both the N- and C-termini (PIII) of the helical peptide. Furthermore, to examine the influence of PI helical chain length on siRNA delivery, truncated peptides containing 16 (PIV), 12 (PV), and 8 (PVI) amino acid residues at the N-terminus of the helical chain were synthesized. PII and PIII, as well as PI, could deliver anti-luciferase siRNA into cells to induce the knockdown of luciferase stably expressed in cells. In contrast, all of the truncated peptides were unlikely to transport siRNA into cells. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2017.11.018 |